REQUEST A DEMO
Total
USD $0.00
Search more companies

Z & Z Reumint Reumatologia - Medicina Interna S.A.S. (Ecuador)

Main Activities: Offices of Physicians
Full name: Z & Z Reumint Reumatologia - Medicina Interna S.A.S. Profile Updated: August 02, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Z & Z Reumint Reumatologia - Medicina Interna S.A.S. is an enterprise in Ecuador, with the main office in Guayaquil. The enterprise operates in the Offices of Physicians industry. The company was established on March 29, 2022. 4 (2023) employees currently work for Z & Z Reumint Reumatologia - Medicina Interna S.A.S.. The company’s latest financial report indicates a net sales revenue drop of 63.51% in 2023. A negative growth of 20.5% was recorded in its total assets. The net profit margin of Z & Z Reumint Reumatologia - Medicina Interna S.A.S. decreased by 27.13% in 2023.

Headquarters
Calle Abel Romeo Castillo
Guayaquil; Guayas;

Contact Details: Purchase the Z & Z Reumint Reumatologia - Medicina Interna S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Z & Z Reumint Reumatologia - Medicina Interna S.A.S. report to view the information.
Outstanding Shares:
Purchase the Z & Z Reumint Reumatologia - Medicina Interna S.A.S. report to view the information.
Registered Capital:
Purchase the Z & Z Reumint Reumatologia - Medicina Interna S.A.S. report to view the information.
Incorporation Date:
March 29, 2022
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Z & Z Reumint Reumatologia - Medicina Interna S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-63.51%
Total operating revenue
-63.51%
Operating profit (EBIT)
-84.25%
Net Profit (Loss) for the Period
-84.93%
Total assets
-20.5%
Total equity
-42.19%
Operating Profit Margin (ROS)
-26.48%
Net Profit Margin
-27.13%
Return on Equity (ROE)
-68.37%
Quick Ratio
-3.33%
Cash Ratio
-0.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?